Evidence map›Paper›PMID 38461416›Full record

ArticleCell reports2024

Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitis.

Yi Luan, Jiajia Hu, Qijun Wang, Xujun Wang, Wenxue Li, Rihao Qu, Chuan Yang, Barani Kumar Rajendran, Hongyue Zhou, Peng Liu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Alleviating Effects ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Review
  5. Biomedicines · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Yi LuanDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Jiajia HuDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Qijun WangDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Xujun WangDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; Yale Stem Cell Center, Yale University, New Haven, CT 06520, USA.
Wenxue LiYale Cancer Biology Institute, West Haven, CT 06516, USA.
Rihao QuDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510, USA.
Chuan YangDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Barani Kumar RajendranDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Hongyue ZhouDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Peng LiuDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA.
Ningning ZhangDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; Yale Stem Cell Center, Yale University, New Haven, CT 06520, USA.
Yu ShiSchool of Management, Yale University, New Haven, CT 06511, USA.
Yansheng LiuYale Cancer Biology Institute, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510, USA. Electronic address: yansheng.liu@yale.edu.
Wenwen TangDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA. Electronic address: wenwen.tang@yale.edu.
Jun LuDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA; Yale Stem Cell Center, Yale University, New Haven, CT 06520, USA. Electronic address: jun.lu@yale.edu.
Dianqing WuDepartment of Pharmacology, Vascular Biology and Therapeutic Program, Yale School of Medicine, New Haven, CT 06519, USA. Electronic address: dianqing.wu@yale.edu.
Yale University · USYale Cancer Center · US

Funding

Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systemsR35HL135805 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2017 to 2023
$6.4M
Role of immune regulation in colorectal cancer chemotherapeutic responseR01CA256530 · NCI · YALE UNIVERSITY · PI LU, JUN · 2021 to 2025
$2.4M
The role of cell surface RNAs in neutrophilsR01AI181308 · NIAID · YALE UNIVERSITY · PI Jun Lu, Dianqing Wu · 2024 to 2026
$2.1M
The role of MAP3K2/3 in modulating neutrophil ROS release and its translational potentialR01HL145152 · NHLBI · YALE UNIVERSITY · PI TANG, WENWEN · 2019 to 2022
$1.7M
NCI NIH HHS R01 CA256530NHLBI NIH HHS R01 HL145152NHLBI NIH HHS R35 HL135805NIAID NIH HHS R01 AI181308
6 · The paper itself

Abstract

Neutrophils are important innate immune cells with plasticity, heterogenicity, and functional ambivalency. While bone marrow is often regarded as the primary source of neutrophil production, the roles of extramedullary production in regulating neutrophil plasticity and heterogenicity in autoimmune diseases remain poorly understood. Here, we report that the lack of wingless-type MMTV integration site family member 5 (WNT5) unleashes anti-inflammatory protection against colitis in mice, accompanied by reduced colonic CD8

Indexed as

ColitisNeutrophilsAnimalsBone MarrowMiceMyelopoiesisCD101colitisCP: Immunologyextramedullary hematopoiesisgranulopoiesisimmune suppressionneutrophilWnt signaling

Identifiers

PMID38461416
PMCPMC11064424
OpenAlexW4392603613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.